Erie Insurance Group
ERIE
$233.67
-5.99%
Erie Indemnity Co performs services for the Erie Insurance Exchange, primarily underwriting and issuing property and casualty insurance policies, including auto, homeowners, and commercial lines. It operates as a unique manager of the Exchange, with its revenue tied to policy issuance and renewal fees, making it a specialized service provider in the P&C insurance industry. The stock has faced significant headwinds, with a 38.5% decline over the past year, driven by underwriting losses and margin compression in the Exchange's results. Investor attention is focused on the company's ability to stabilize underwriting performance and return to profitable growth amid a challenging claims environment.…
ERIE
Erie Insurance Group
$233.67
ERIE 12-Month Price Forecast
Wall Street consensus
Insufficient analyst coverage available. Only one analyst covers the stock, with no explicit recommendation or target price provided. The limited coverage implies that Erie is a smaller-cap, less-followed name, which can lead to higher volatility and less efficient price discovery. The consensus EPS estimate for the current year is $12.70, with revenue estimated at $4.61 billion. Without a target price, investors must rely on fundamental analysis and valuation comparisons. The lack of analyst coverage means that the stock may be overlooked by institutional investors, but it also reduces the risk of consensus-driven sell-offs. The wide range of historical P/E multiples (20x-52x) suggests that the stock's valuation is highly sensitive to earnings expectations, and the current low coverage amplifies uncertainty.
Bulls vs Bears: ERIE Investment Factors
Erie Indemnity presents a mixed picture: a strong balance sheet (zero debt, 1.24 current ratio) and high ROE (24.5%) are offset by a 38.5% stock decline, decelerating revenue growth (2.3% YoY), and margin compression (net margin down to 14.9%). The bull case rests on the forward P/E of 15.0x being near historical lows, implying a recovery in earnings, while the bear case highlights the persistent downtrend and lack of near-term catalysts. The single most important tension is whether the Exchange's underwriting performance can stabilize—if claims costs moderate and margins recover, the stock could re-rate higher; if not, further downside toward the 52-week low of $204.63 is possible. Currently, the bearish evidence is stronger given the negative momentum and fundamental deterioration.
Bullish
- Zero debt and strong liquidity: Erie Indemnity has a debt-to-equity ratio of 0 and a current ratio of 1.24, indicating a fortress balance sheet with ample liquidity to weather underwriting cycles. This financial stability is rare in the P&C insurance sector and provides a margin of safety.
- Forward P/E near historical low: The forward P/E of 15.0x is near the lower end of its five-year range of 20x-52x, suggesting the stock is cheap relative to its own history. If earnings recover as analysts expect, the multiple could expand, offering significant upside.
- High ROE of 24.5%: Erie's return on equity of 24.5% demonstrates efficient capital use and strong profitability relative to book value. This metric is well above the industry average, reflecting the company's competitive advantages in its niche.
- Unique business model with recurring fees: Erie's revenue is tied to policy issuance and renewal fees from the Erie Insurance Exchange, providing a stable, recurring income stream. This model insulates it from direct underwriting risk, though it is still exposed to the Exchange's performance.
Bearish
- 38.5% stock decline in one year: The stock has fallen 38.5% over the past year, dramatically underperforming the S&P 500's +20.9% gain. This severe decline reflects persistent underwriting losses at the Exchange and margin compression, with no clear catalyst for reversal.
- Declining net income and margins: Net income fell to $150.5 million in Q1 2026 from $174.7 million in Q2 2025, and net margin dropped to 14.9% from 16.5%. Operating margin also contracted to 16.4% from 18.8%, indicating cost pressures and worsening profitability.
- Revenue growth decelerating sharply: Revenue growth slowed to 2.3% YoY in Q1 2026, down from 7.1% in Q1 2025. This deceleration signals weakening policy issuance volumes and premium growth, limiting top-line momentum.
- Low analyst coverage and no consensus target: Only one analyst covers Erie, with no explicit recommendation or target price. This lack of coverage reduces visibility and can lead to higher volatility, as there is less institutional support to stabilize the stock.
ERIE Technical Analysis
Erie Indemnity is in a sustained downtrend, with the stock price declining 38.5% over the past year. The current price of $210.19 sits at 55.2% of its 52-week range (low $204.63, high $380.67), indicating it is near the bottom of the range. This positioning suggests the stock is deeply oversold and may be approaching a value zone, but the persistent downtrend warns of potential further downside. The 1-year price change of -38.5% versus the S&P 500's +20.9% highlights severe relative underperformance. Short-term momentum remains negative, with the 1-month price change at -6.2% and the 3-month change at -12.9%. The 1-month decline of 6.2% is accelerating compared to the 3-month decline, indicating worsening near-term sentiment. This divergence from the longer-term downtrend could signal a capitulation phase, but the lack of a clear reversal pattern suggests continued weakness. The stock's beta of 0.286 implies it is significantly less volatile than the market, meaning the decline is driven by company-specific factors rather than broad market moves. The 52-week low of $204.63 provides immediate support, while the 52-week high of $380.67 is a distant resistance. A break below $204.63 could trigger further selling, while a recovery above $250 would be needed to suggest a trend reversal. The low beta (0.286) indicates that Erie is not a high-volatility name, so the current drawdown is particularly concerning for a typically stable stock.
Beta
0.29
0.29x market volatility
Max Drawdown
-43.8%
Largest decline past year
52-Week Range
$205-$381
Price range past year
Annual Return
-33.9%
Cumulative gain past year
| Period | ERIE Return | S&P 500 |
|---|---|---|
| 1m | -2.5% | -0.7% |
| 3m | +8.7% | +2.9% |
| 6m | -17.4% | +7.2% |
| 1y | -33.9% | +16.9% |
| ytd | -15.9% | +8.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ERIE Fundamental Analysis
Revenue growth has been modest but decelerating. In Q1 2026, revenue was $1.012 billion, up 2.3% year-over-year, compared to 7.1% growth in Q1 2025. The trailing twelve-month revenue is approximately $4.04 billion. The primary revenue driver is policy issuance and renewal services, which generated $786 million in the latest quarter, while service agreement revenue was only $5.9 million. The deceleration in revenue growth reflects a slowdown in policy issuance volumes and premium growth, which is a concern for the investment case as it suggests limited top-line momentum. Profitability has been under pressure. Net income in Q1 2026 was $150.5 million, down from $174.7 million in Q2 2025, and net margin fell to 14.9% from 16.5% a year earlier. Gross margin remains thin at 14.5% in Q1 2026, consistent with the insurance industry's low margin structure. Operating margin was 16.4%, down from 18.8% in Q2 2025, indicating cost pressures. The company is profitable, but margins are compressing, which is a red flag for earnings sustainability. The balance sheet is strong with zero debt (debt-to-equity ratio of 0) and a current ratio of 1.24, indicating ample liquidity. Free cash flow was $54.5 million in Q1 2026, down from $88.4 million in Q1 2025, but the TTM free cash flow is $537 million. ROE is 24.5%, reflecting efficient capital use, but the declining net income trend warrants caution. The company generates sufficient cash to fund operations and dividends (payout ratio of 45.5%), but the weakening free cash flow trend is a concern.
Quarterly Revenue
$1.0B
2026-03
Revenue YoY Growth
+2.3%
YoY Comparison
Gross Margin
14.5%
Latest Quarter
Free Cash Flow
$536999000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ERIE Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 23.9x, while the forward P/E is 15.0x, implying the market expects significant earnings growth. The gap between trailing and forward P/E suggests that analysts anticipate a sharp recovery in earnings, which is optimistic given the current margin compression. Compared to the industry average P/E (not provided, but typically around 15-20x for P&C insurers), Erie's trailing P/E of 23.9x appears elevated. However, the forward P/E of 15.0x is more in line with the sector, indicating that the market is pricing in a normalization of earnings. The premium on trailing earnings may be justified by Erie's unique business model and strong competitive position, but the forward multiple suggests limited upside if earnings fail to recover. Historically, Erie's trailing P/E has ranged from 20x to 52x over the past five years. The current trailing P/E of 23.9x is near the lower end of this range, suggesting the stock is relatively cheap compared to its own history. The historical low P/E of 20x was in mid-2023, while the high of 52x was in Q4 2025 when earnings were depressed. The current multiple implies that the market is pricing in a recovery but not yet at peak optimism. The price-to-book ratio of 5.8x is also below the historical average of around 8-10x, further supporting the view that valuation is compressed.
PE
23.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~53x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Erie's profitability is under pressure, with net income declining 13.9% from Q2 2025 to Q1 2026 and net margin falling from 16.5% to 14.9%. Free cash flow also dropped 38.3% year-over-year to $54.5 million in Q1 2026, though TTM FCF remains healthy at $537 million. The company has zero debt, so financial leverage is not a concern, but the declining earnings trend could lead to dividend cuts if it persists. Revenue concentration in the Exchange's performance is a key operational risk—any deterioration in the Exchange's underwriting results directly impacts Erie's fee income.
Market & Competitive Risks: The stock's beta of 0.286 indicates low market correlation, meaning the decline is company-specific rather than macro-driven. However, the 38.5% one-year loss versus the S&P 500's 20.9% gain highlights severe relative underperformance, which could persist if the Exchange's results do not improve. The P&C insurance sector is competitive, and Erie's unique model does not shield it from industry-wide claims inflation. With only one analyst covering the stock, there is a risk of limited price discovery and potential for sharp moves on any news.
Worst-Case Scenario: If underwriting losses at the Exchange continue to mount, leading to further margin compression and a dividend cut, the stock could fall to its 52-week low of $204.63, representing a 2.6% downside from the current price of $210.19. However, if the Exchange's financial health deteriorates significantly, the stock could break below that level, with the next support around $190 (a 9.6% decline). The historical max drawdown of -43.83% suggests that in a severe scenario, the stock could fall to approximately $118, a 43.8% loss from current levels.